Our Firm’s attorneys continue to represent numerous women in lawsuits against several manufacturers.
New York, NY (PRWEB) February 01, 2015
Status conferences in all seven federal transvaginal mesh (http://www.filevaginalmeshlawsuit.com/) litigations will take place the first week of February in the Southern District of West Virginia, Bernstein Liebhard LLP reports.
According to recent court documents, the meetings will be conducted on February 5, 2015 at 10:00 a.m. in the U.S. District Court, Southern District of West Virginia and will discuss lawsuits filed over pelvic implants manufactured by Boston Scientific Corp., the Johnson & Johnson subsidiary, Ethicon Inc., C.R Bard and American Medical Systems, in addition to other companies. Claims included in these litigations involve products that were designed to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in women.
“We are looking forward to status conferences in the numerous transvaginal mesh litigations now underway in the U.S. District Court, Southern District of West Virginia, as our Firm’s attorneys continue to represent numerous women in lawsuits against several manufacturers,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including transvaginal mesh. The Firm is offering free and confidential case evaluations to women who were allegedly harmed by products manufactured by C.R. Bard, Johnson & Johnson’s Ethicon unit, American Medical Systems and Boston Scientific Corp.
Transvaginal Mesh Lawsuits
According to court documents, the numerous transvaginal mesh litigations currently underway in the Southern District of West Virginia have continued to mount since 2008, when the U.S. Food and Drug Administration (FDA) first warned about the risk for vaginal mesh complications. At the time, the potential was categorized as “rare,” a stance that was augmented in 2011 to reflect approximately 3,000 new adverse event reports that had been filed by women over the three-year period. These complaints alleged instances of mesh erosion and other injuries that were sustained after implantation of the mesh, the FDA said in a notice issued that July.
Three years later, the FDA took its most recent step in addressing transvaginal mesh issues by proposing in April 2014 that the implants be classified as “high-risk.” If the new regulations pass, manufacturers would be required to submit their devices for pre-market approval, which would subject them to greater regulatory oversight and rigorous safety testing.*
Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is currently serving on the Plaintiffs’ Steering Committees in all seven transvaginal mesh litigations underway in West Virginia: (In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.)
Additionally, Mr. Grand is also serving as Co-Liaison Counsel in two separate transvaginal mesh litigations underway in New Jersey’s Bergen County Superior Court, where cases involving products from C.R. Bard and Johnson & Johnson’s Ethicon have been consolidated. For the Ethicon proceeding, Mr. Grand served on the plaintiff’s trial team for a case that concluded in March 2013 with an $11 million damage award to a woman who was injured by the Gynecare Prolift implant she received. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who allege serious complications of transvaginal mesh may be eligible to receive compensation for lost wages, medical bills, pain and suffering and other injury-related damages. Learn more about vaginal mesh complications by visiting Bernstein Liebhard LLP’s website, or Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm395192.htm, U.S. Food and Drug Administration (FDA), April 29, 2014.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP